tiprankstipranks
Trending News
More News >
U.s. Physical Therapy (USPH)
NYSE:USPH
US Market

US Physical Therapy (USPH) Ratios

Compare
139 Followers

US Physical Therapy Ratios

USPH's free cash flow for Q4 2025 was $0.21. For the 2025 fiscal year, USPH's free cash flow was decreased by $ and operating cash flow was $0.09. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.01 1.01 1.18 2.28 1.30
Quick Ratio
1.01 1.01 1.18 2.28 1.30
Cash Ratio
0.26 0.26 0.36 1.50 0.37
Solvency Ratio
0.09 0.09 0.11 0.09 0.12
Operating Cash Flow Ratio
0.54 0.54 0.64 0.80 0.68
Short-Term Operating Cash Flow Coverage
1.44 1.44 6.81 10.66 7.44
Net Current Asset Value
$ -293.82M$ -293.82M$ -270.84M$ -111.63M$ -262.32M
Leverage Ratios
Debt-to-Assets Ratio
0.35 0.35 0.25 0.26 0.34
Debt-to-Equity Ratio
0.89 0.89 0.60 0.54 0.94
Debt-to-Capital Ratio
0.47 0.47 0.38 0.35 0.48
Long-Term Debt-to-Capital Ratio
0.36 0.36 0.23 0.23 0.36
Financial Leverage Ratio
2.53 2.53 2.39 2.09 2.72
Debt Service Coverage Ratio
1.46 1.46 3.80 3.66 4.69
Interest Coverage Ratio
9.72 8.50 7.89 5.60 9.83
Debt to Market Cap
0.26 0.27 0.11 0.11 0.17
Interest Debt Per Share
28.68 28.68 20.13 18.88 23.19
Net Debt to EBITDA
3.56 3.56 2.92 1.42 3.47
Profitability Margins
Gross Profit Margin
22.16%20.15%18.46%20.09%20.25%
EBIT Margin
12.77%11.17%10.16%9.70%11.09%
EBITDA Margin
16.04%14.04%12.94%12.30%13.76%
Operating Profit Margin
13.45%10.30%9.42%8.61%10.27%
Pretax Profit Margin
11.38%9.96%8.97%8.16%10.05%
Net Profit Margin
2.25%1.93%3.94%2.43%5.11%
Continuous Operations Profit Margin
8.49%7.43%6.79%6.15%7.85%
Net Income Per EBT
19.80%19.36%43.95%29.72%50.87%
EBT Per EBIT
84.66%96.74%95.25%94.84%97.83%
Return on Assets (ROA)
1.28%1.25%2.27%1.47%3.29%
Return on Equity (ROE)
3.12%3.16%5.41%3.08%8.95%
Return on Capital Employed (ROCE)
8.63%7.55%6.01%5.82%7.35%
Return on Invested Capital (ROIC)
6.13%5.37%4.34%4.18%5.45%
Return on Tangible Assets
4.55%4.45%8.24%3.88%11.07%
Earnings Yield
1.25%1.27%1.98%1.11%2.69%
Efficiency Ratios
Receivables Turnover
10.64 12.16 7.84 11.66 8.06
Payables Turnover
87.81 102.93 92.22 123.98 67.82
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
2.52 2.88 4.04 4.67 4.33
Asset Turnover
0.57 0.65 0.58 0.61 0.64
Working Capital Turnover Ratio
56.24 70.20 8.81 7.71 29.53
Cash Conversion Cycle
30.15 26.48 42.62 28.36 39.89
Days of Sales Outstanding
34.31 30.03 46.58 31.30 45.27
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
4.16 3.55 3.96 2.94 5.38
Operating Cycle
34.31 30.03 46.58 31.30 45.27
Cash Flow Ratios
Operating Cash Flow Per Share
4.95 4.95 4.97 5.78 4.51
Free Cash Flow Per Share
4.02 4.02 4.36 5.12 3.87
CapEx Per Share
0.93 0.93 0.61 0.66 0.64
Free Cash Flow to Operating Cash Flow
0.81 0.81 0.88 0.89 0.86
Dividend Paid and CapEx Coverage Ratio
1.55 1.81 2.10 2.45 1.98
Capital Expenditure Coverage Ratio
5.33 5.33 8.16 8.82 7.10
Operating Cash Flow Coverage Ratio
0.18 0.18 0.25 0.32 0.20
Operating Cash Flow to Sales Ratio
0.11 0.10 0.11 0.14 0.11
Free Cash Flow Yield
4.95%5.15%4.92%5.50%4.78%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
79.85 78.68 50.50 90.06 37.22
Price-to-Sales (P/S) Ratio
1.80 1.52 1.99 2.18 1.90
Price-to-Book (P/B) Ratio
2.58 2.49 2.73 2.78 3.33
Price-to-Free Cash Flow (P/FCF) Ratio
20.22 19.43 20.32 18.18 20.92
Price-to-Operating Cash Flow Ratio
16.39 15.79 17.83 16.12 17.97
Price-to-Earnings Growth (PEG) Ratio
-1.98 -3.45 1.15 -1.46 -1.45
Price-to-Fair Value
2.58 2.49 2.73 2.78 3.33
Enterprise Value Multiple
14.80 14.36 18.30 19.19 17.29
Enterprise Value
1.62B 1.58B 1.59B 1.43B 1.32B
EV to EBITDA
14.80 14.36 18.30 19.19 17.29
EV to Sales
2.37 2.02 2.37 2.36 2.38
EV to Free Cash Flow
26.61 25.83 24.18 19.64 26.17
EV to Operating Cash Flow
21.62 20.99 21.22 17.41 22.48
Tangible Book Value Per Share
-6.26 -6.26 -5.80 2.32 -9.11
Shareholders’ Equity Per Share
31.40 31.40 32.46 33.56 24.32
Tax and Other Ratios
Effective Tax Rate
0.25 0.25 0.24 0.25 0.22
Revenue Per Share
45.04 51.47 44.57 42.63 42.60
Net Income Per Share
1.02 0.99 1.76 1.03 2.18
Tax Burden
0.20 0.19 0.44 0.30 0.51
Interest Burden
0.89 0.89 0.88 0.84 0.91
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.05 0.00 0.09 0.00 0.08
Stock-Based Compensation to Revenue
0.01 0.01 0.01 0.01 0.01
Income Quality
1.48 1.29 1.64 2.20 1.35
Currency in USD